Pure Global
NCT06416254

The Fibre Full Study

The Effects of a Diet Enriched With Dietary Fibre on Glycaemic Response, Gastrointestinal Tolerability, Satiety, and Microbiome Functionality (The Fibre Full Study).
University College Cork·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Overweight and Obesity
Drug/Device/Intervention
Fibre-enriched diet
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University College Cork
Location
Cork, Ireland
Timeline & enrollment
Phase
N/A
Start date
Mar 28, 2024
End date
Dec 01, 2025
Enrollment
20 participants
Primary outcome

Impact of a fibre-enriched diet on glycaemic control,Differences in participant reported satiety when consuming the fibre-enriched diet compared to the matched control diet

Summary

This study will systematically investigate the effects of a diet with decreased energy
 density, reduced glycaemic index, and significantly increased dietary fibre, on post-prandial
 glycaemic response, satiety, gastrointestinal tolerability and gut microbiota composition and
 function in individuals with excess body weight (Body Mass Index (BMI) 25-35kg/m2).
 
 Hypothesis: The investigators hypothesise that a diet enriched in fibre will be beneficial to
 post-prandial glycaemic response, well tolerated and satiating, as compared to the standard
 Western-style diet.

ICD-10 classifications
ObesityOther obesityObesity due to excess caloriesObesity, unspecifiedObesity and other hyperalimentation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06416254
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06416254 through Pure Global AI's free database. This phase not specified trial is sponsored by University College Cork and is currently Recruiting. The study focuses on Overweight and Obesity. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.